Press Release Archives | Page 3 of 4 | CereVasc | Neurological Disease Device Company

07 Feb, 2024

CereVasc’s eShunt® System to be Presented at the International Stroke Conference by Dr. Pedro Lylyk

cerevasc2024-05-10T14:17:27+00:00February 7th, 2024|

23 Jan, 2024

CereVasc’s eShunt® System Study Data Presented at the ABC WIN Seminar

cerevasc2024-10-14T16:28:16+00:00January 23rd, 2024|

03 Oct, 2023

CereVasc Announces 30th Patient Treated in Pilot Studies of the eShunt® System to treat Communicating Hydrocephalus

Admin2023-12-20T22:01:46+00:00October 3rd, 2023|

26 Sep, 2023

CereVasc eShunt® System Study Data Presented at Congress of Neurological Surgeons Meeting

Admin2023-11-06T22:49:34+00:00September 26th, 2023|

18 Sep, 2023

CereVasc Receives FDA IDE Approval to Expand its Clinical Study of Patients with Normal Pressure Hydrocephalus Utilizing the Generation 2 eShunt® System

Admin2023-11-06T22:46:27+00:00September 18th, 2023|

13 Sep, 2023

CereVasc eShunt® System Study Data Presented at the European Society of Minimally Invasive Neurological Therapy (ESMINT) Congress in Marseille

Admin2023-11-06T22:43:59+00:00September 13th, 2023|

26 Jun, 2023

CereVasc & LianMedical Announce Corporate Partnership

Admin2023-11-06T22:31:47+00:00June 26th, 2023|

14 Jun, 2023

CereVasc’s Minimally Invasive Central Nervous System Therapy Delivery System Receives Outstanding Presentation Award at American Society of Gene & Cell Therapy Annual Meeting

Admin2023-11-06T22:29:02+00:00June 14th, 2023|

04 May, 2023

CereVasc to Present Data on its Minimally Invasive CNS Delivery System at Upcoming American Society of Gene and Cell Therapy Annual Meeting

Admin2023-11-06T22:08:22+00:00May 4th, 2023|

28 Mar, 2023

CereVasc Appoints Dr. Adel Malek Chief Medical Officer

Admin2023-11-06T22:03:27+00:00March 28th, 2023|